| Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer I Jones, L Dent, T Higo, T Roumeliotis, M Arias Garcia, H Shree, ... Science Advances 9 (4), eadd0636, 2023 | 10 | 2023 |
| Environmentally dependent and independent control of 3D cell shape LG Dent, N Curry, H Sparks, V Bousgouni, V Maioli, S Kumar, I Munro, ... Cell Reports 43 (5), 2024 | 4 | 2024 |
| ARHGEF9 regulates melanoma morphogenesis in environments with diverse geometry and elasticity by promoting filopodial-driven adhesion V Bousgouni, O Inge, D Robertson, I Jones, I Clatworthy, C Bakal Iscience 25 (8), 2022 | 4 | 2022 |
| Homogeneous 2D and 3D alignment of cardiomyocyte in dilated cardiomyopathy revealed by intravital heart imaging K Masuyama, T Higo, JK Lee, R Matsuura, I Jones, C Bakal, S Higo, ... Scientific Reports 11 (1), 14698, 2021 | 4 | 2021 |
| Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell system C Badja, S Momen, GCC Koh, S Boushaki, TI Roumeliotis, Z Kozik, ... Cell Reports 43 (6), 2024 | 2 | 2024 |
| Meeting report–Cell size and growth: from single cells to the tree of life D Chatzitheodoridou, M D'Ario, I Jones, L Piñeros, D Serbanescu, ... Journal of Cell Science 135 (20), jcs260634, 2022 | 1 | 2022 |
| On the Co-Dependence of Cell Morphology and Biochemistry in Cancer I Jones Institute of Cancer Research (University Of London), 2024 | | 2024 |
| YAP activation is robust to dilution I Jones, M Arias-Garcia, P Pascual-Vargas, M Beykou, L Dent, ... Molecular Omics, 2024 | | 2024 |
| A rare genetic disorder provides insights into mechanisms of early-onset neurodegeneration C Badja, S Momen, GCC Koh, S Boushaki, TI Roumeliotis, Z Kozik, ... medRxiv, 2023.05. 22.23290124, 2023 | | 2023 |
| Coupling of Nuclear Translocation to Cell Size Promotes Robustness to Fluctuations in YAP/TAZ Concentration I Jones, M Arias-Garcia, P Pascual-Vargas, M Beykou, L Dent, ... bioRxiv, 2023.02. 06.527281, 2023 | | 2023 |
Chris BakalTeam Leader, Chester Beatty Laboratories, Institute of Cancer Research在 icr.ac.uk 的电子邮件经过验证
